← Evidence map

ArticleCancers2026

Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.

José Del Corral-Morales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026

this papercites it

Impact of Immune-Related Adverse Event Frequency, Severity and Corticosteroid Use on Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer. | OpenQuestion